Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
A031701
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
- NCT03609216 ↗
- Active, not recruiting
- Alliance for Clinical Trials in Oncology
- Focused
We haven't built an HCP commentary report on A031701 (gemcitabine hydrochloride, pegfilgrastim and 1 more in Infiltrating Bladder Urothelial Carcinoma) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on A031701 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 5 |
The trial
ClinicalTrials.gov- Official title
- A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- Infiltrating Bladder Urothelial Carcinoma; Stage II Bladder Urothelial Carcinoma; Stage III Bladder Urothelial Carcinoma
- Interventions
- Gemcitabine Hydrochloride; Cisplatin; Pegfilgrastim; Conventional Surgery; Radical Cystectomy; Chemoradiotherapy
- Arms
- Arm I (gemcitabine, cisplatin, bladder sparing) · Experimental
- Arm II (gemcitabine, cisplatin, cystectomy, chemoradiotherapy) · Experimental
- Enrollment
- 237
- Primary outcomes
- Proportion of patients who are recurrence-free within the DDR mutated group who undergo the bladder sparing approach
- Sponsor
- Alliance for Clinical Trials in Oncology with National Cancer Institute (NCI)
- Start
- Dec 10, 2018
- Primary completion
- Oct 14, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT03609216 · updated Oct 16, 2026